Test Price
2,800 AED✅ Home Collection Available
NDUFS4 Gene Sequencing (Mitochondrial Complex I Deficiency) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NDUFS4 لنقص المركب الأول في الميتوكوندريا في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Clinical Summary
ملخص تنفيذي: يوفر تحليل تسلسل الجينوم من الجيل التالي (NGS) لجين NDUFS4 تشخيصًا جزيئيًا دقيقًا لنقص المركب الأول في الميتوكوندريا، وهو مرض تنكسي عصبي شديد. بدقة تشخيصية تبلغ 99.9%، يضمن هذا الاختبار المعتمد من DHA وISO 9001:2015 (الشهادة: INT/EGQ/2509DA/3139) الوضوح الجيني للعائلات المتضررة في دولة الإمارات، ملتزماً بالمرسوم بقانون اتحادي رقم 41 لسنة 2024. تتضمن خدمتنا المتميزة جمع العينات منزلياً بسلسلة تبريد معتمدة، واستشارة وراثية شاملة قبل وبعد الاختبار، وتوجيه سريري هاتفي.
Clinical Overview & Comparative Utility
The NDUFS4 Gene NGS Test analyzes the entire coding region of the NDUFS4 gene using Next Generation Sequencing to identify pathogenic variants causative of mitochondrial complex I deficiency, a severe neurometabolic disorder. This NGS technology offers single-nucleotide resolution and is the definitive molecular standard, replacing less sensitive legacy panel assays, for confirming a clinical diagnosis, guiding familial screening in accordance with Federal Decree-Law No. 41 of 2024 on genetic disease prevention, and enabling proactive neurological management.
| Feature | Our Test: NDUFS4 NGS Gene Sequencing | Closest Alternative: Targeted Genotyping Panel |
|---|---|---|
| Precision & Yield | Full gene sequencing; identifies novel & rare variants. | Pre-defined hotspots only; misses rare mutations. |
| Clinical Methodology | NGS (Next-Generation Sequencing) with advanced bioinformatics. | PCR-based Sanger Sequencing of limited loci. |
| Turnaround & Scope | Comprehensive in 3-4 Weeks. | Fragmented results requiring iterative testing. |
Physician Insight & Safety Protocol
A Message from Dr. PRABHAKAR REDDY, DHA License: 61713011:
"A diagnosis of mitochondrial complex I deficiency can be profoundly disorienting for a family; this test is not merely a lab value but the foundational blueprint for personalizing your child's neurologist-led care plan. The NDUFS4 variant information is critical, yet the clinical picture must remain our compass—please know that a positive result must be integrated with neurological assessment, while a negative one does not exclude other forms of mitochondrial disease. Your active partnership is your family's most potent therapeutic asset."
⚠ Critical Medication & Safety Warning
Do not discontinue, modify, or initiate any prescribed medication, vitamins, or cofactors, including valproic acid, barbiturates, or specific antibiotics, without explicit consultation with your treating neurologist. This genetic information is diagnostic and requires expert clinical correlation to avoid severe metabolic decompensation.
Exclusion & Emergency Protocol
- Exclusion Criteria: Inability to provide a valid clinical history or participate in the mandated pre-test genetic counselling session as per UAE CDS Law 2026 for minors. Samples must be collected strictly by our DHA-licensed phlebotomists.
- When to seek Emergency Care (ER Red Flags): If the patient experiences sudden onset of metabolic crisis symptoms such as acute lethargy, intractable vomiting, seizures, or loss of motor skills, report to the nearest hospital immediately.
Patient FAQ & Clinical Guidance
What does a positive NDUFS4 gene test mean for my child's neurological development?
A positive NDUFS4 gene test confirms a genetic diagnosis of mitochondrial complex I deficiency, pinpointing the precise cause of potential neurological regression, Leigh syndrome-like brain lesions, and movement disorders observed on MRI, which enables precise prognostic counselling and targeted therapeutic support. Clinical correlation by a pediatric neurologist is mandatory to differentiate it from other mitochondrialopathies and to initiate a personalized disease management strategy.
هل يمكن إجراء اختبار جين NDUFS4 باستخدام عينة من بطاقة FTA بدلاً من سحب الدم الوريدي للرضيع؟
نعم، بالتأكيد يقبل مختبرنا المعتمد عينة من دم الإصبع على بطاقة FTA كبديل أقل توغلاً لسحب الدم الكامل، مما يوفر استقرارًا ممتازًا للحمض النووي ومطابقًا تامًا لبروتوكولات تسلسل الجيل التالي (NGS) الحساسة لدينا دون المساس بالدقة التشخيصية. يتم إرسال مجموعة أدوات الجمع المنزلي المعقمة مع التعليمات الكاملة وخدمة استلام ساعي التبريد الفورية لضمان سلامة العينة.
Why is a 3-to-4-week turnaround needed for this specific genetic, and how are my data protected?
The 3-to-4-week TAT comprises exhaustive DNA library preparation, high-depth NGS sequencing achieving a 100x minimum mean coverage, and rigorous multi-stage bioinformatic annotation against ClinVar and mitochondrial genome databases for absolute variant accuracy, followed by clinical PhD scientist review. Your genomic data is secured and anonymized in compliance with the UAE PDPL and ISO 9001:2015 data integrity standards, with strict access controls beyond the clinical reporting team.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians